Edition:
United Kingdom

People: Qiagen NV (QGEN.N)

QGEN.N on New York Stock Exchange

38.30USD
18 Apr 2019
Change (% chg)

$-0.23 (-0.60%)
Prev Close
$38.53
Open
$38.58
Day's High
$38.68
Day's Low
$37.97
Volume
801,135
Avg. Vol
339,226
52-wk High
$41.52
52-wk Low
$31.95

Sackers, Roland 

Mr. Roland Sackers has served as Managing Director, Chief Financial Officer, Member of the Executive Committee of Qiagen N.V. since 2016. He joined the Company in 1999 as Vice President Finance and has been Chief Financial Officer since 2004. In 2006, Mr. Sackers became a member of the Managing Board. Between 1995 and 1999, he served as an auditor with Arthur Andersen Wirtschaftsprüfungsgesellschaft Steuerberatungsgesellschaft. Mr. Sackers earned his Master Degree Business Administration (Diplom-Kaufmann) from Westfaelische Wilhelms-Universitaet Muenster. He is a former member of the Supervisory Board and Audit Committee of IBS AG and a former member of the board of directors of Operon Biotechnologies, Inc. Mr. Sackers is a board member of the industry association BIO Deutschland. He is also a non-executive director and chair of the audit committee of Immunodiagnostic Systems Holding PLC (IDS), a producer of immunological tests for research and diagnostic applications publicly listed in the United Kingdom.

Basic Compensation

Total Annual Compensation, USD 612,000
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD 277,000
All Other, USD --
Fiscal Year Total, USD 889,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --